U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents

Amgen Inc sought to convince the U.S. Supreme Court on Monday to revive patents on its cholesterol-lowering drug Repatha, while rival Sanofi SA urged the justices not to stifle competition for therapies to address a common health risk.

Related Keywords

France ,Washington ,United States ,French ,Joe Biden ,Blake Brittain ,Justice Ketanji Brown Jackson ,Paul Clement ,Andrew Chung ,Justice Clarence Thomas ,John Kruzel ,Jeffrey Lamken ,Reuters ,Regeneron Pharmaceuticals Inc ,Thomson Reuters Trust Principles ,Us Supreme Court On ,Us Court ,Amgen ,Amgen Inc ,California Based Amgen ,Federal Circuit ,Thomson Reuters Trust ,